PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550565
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550565
Molecular Diagnostics Market, By Product Type, By Application, By End-User, By Geography
The global molecular diagnostics market is estimated to be valued at USD 16.33 Billion in 2024 and is expected to reach USD 36.55 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 12.2% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 16.33 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 12.20% | 2031 Value Projection: | US$ 36.55 Bn |
Molecular diagnostics is an evolving field that involves the analysis of biological markers, or biomarkers, at the molecular level to test for diseases, predict risk or identify new therapeutic options. Molecular diagnostics has become a fundamental tool in modern healthcare, helping clinicians detect and monitor disease along with making treatment decisions. The ability to detect biomarkers through techniques such as DNA sequencing and polymerase chain reaction (PCR) has revolutionized medical testing and significantly improved patient outcomes. Advances in molecular diagnostic techniques coupled with the declining costs of genetic sequencing are helping drive widespread adoption across various applications areas such as infectious disease testing, oncology and personalized medicine. Continued research and development is further expanding analytical capabilities which is expected to contribute to the ongoing expansion of the market.
Market Dynamics:
The global molecular diagnostics market is witnessing strong growth driven by several factors. Rising prevalence of chronic and infectious diseases worldwide have increased the need for advanced diagnostic techniques. Molecular diagnostic tests offer earlier, more accurate detection of diseases compared to conventional methods. Growing demand for personalized medicine and companion diagnostics is another key driver as molecular tests help identify the most effective therapies for individual patients. Technological advancements enabling high-throughput screening, automated workflow processes and decentralized testing environments are expanding molecular diagnostic capabilities. However, high costs of instruments and lack of skilled labor restrain the market growth. Ongoing reductions in sequencing costs along with the development of portable, easy-to-use instruments opens opportunities in new applications areas, especially in decentralized, point-of-care settings.
Key Features of the Study:
This report provides in-depth analysis of the global molecular diagnostics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global molecular diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin SPA, Hologic Inc., QIAGEN N.V., Roche Diagnostics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global molecular diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular diagnostics market.
Detailed Segmentation-
- By Product Type
- Reagents & Kits
- Instruments
- By Application
- Oncology
- Genetic Testing
- Microbiology
- STDs
- Blood Screening
- Virology
- Tissue Typing
- Prenatal Diagnosis
- Others
- By End-user
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Point-of-Care Settings
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Key Players Insights
- Hoffmann-La Roche Ltd
- Illumina, Inc.
- Hologic, Inc.
- Agilent Technologies Inc.
- Qiagen N.V.
- Myriad Genetics
- Becton, Dickinson and Company
- Abbott Laboratories
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Danaher Corporation (Beckman Coulter Inc.)
- Thermo Fisher Scientific Inc.
- Siemens Healthineers AG
- Johnson & Johnson
- Alere Inc.
- Cepheid
- Gen-Probe Incorporated
- LabCorp (Monogram Biosciences)
- Novartis AG
Table of Contents
1. RESEARCH OBJECTIVES AND ASSUMPTIONS
- Research Objectives
- Assumptions
- Abbreviations
2. MARKET PURVIEW
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Molecular Diagnostics Market, By Product Type
- Global Molecular Diagnostics Market, By Application
- Global Molecular Diagnostics Market, By End-User
- Global Molecular Diagnostics Market, By Region
3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Molecular Diagnostics Market, By Product Type, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Reagents & Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Molecular Diagnostics Market, By Application, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Microbiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- STDs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Blood Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Virology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Tissue Typing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Prenatal Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Molecular Diagnostics Market, By End-User, 2024-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hospitals and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Point-of-Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Molecular Diagnostics Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application , 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End-User , 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. COMPETITIVE LANDSCAPE
- Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qiagen N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Myriad Genetics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Danaher Corporation (Beckman Coulter Inc.)
- Thermo Fisher Scientific Inc.
- Siemens Healthineers AG
- Johnson & Johnson
- Alere Inc.
- Cepheid
- Gen-Probe Incorporated
- LabCorp (Monogram Biosciences)
- Novartis AG
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
